Important Notice: The information on this website is not intended for use within the UK.

Access to Treatment Atlas

Explore. Compare. Advocate.

The Access to Treatment Atlas helps you explore and compare access to lung cancer treatments across Europe. Whether you’re a patient advocate, healthcare professional, researcher or policymaker, the Atlas brings together the information you need in one place.

Why use the Atlas?

Access to treatment varies across Europe. The Access to Treatment Atlas makes those differences easier to understand by bringing together reliable, easy-to-navigate information in a single platform.

Created by patient advocates to support patient advocacy, the Atlas helps you compare treatment availability, reimbursement and country-specific information, while providing access to additional resources that support informed decision-making.

What you can do

01

Compare treatments across Europe

See how treatment availability and reimbursement differ between countries.

02

Search and filter with ease

Use improved search, filtering and comparison tools to find the information you need quickly.

03

Share information

Copy and share direct links to treatments and country pages with colleagues and stakeholders.

04

Find country-specific information

Explore dedicated country pages with treatment information and key healthcare resources.

05

Access additional resources

Find information on lung cancer screening, biomarker testing and clinical trials directly within the platform.

Built for the lung cancer community

The Atlas has been designed to evolve alongside the lung cancer community. If you notice information that is missing, out of date, or if treatments and resources available in your country are not yet included, you can submit feedback directly through the platform. Your input helps us keep the Atlas accurate, relevant and up to date for everyone.

Explore the Atlas

Start exploring treatment access across Europe through our interactive map.